Normal p53 gene makes breast cancer chemotherapy with doxorubicin less effective

[News]

Presence of normal p53, a tumor suppressor gene, instead of a mutated version, makes breast cancer chemotherapy with doxorubicin less effective. The preclinical study led by MD Anderson scientists was published today in the journal Cancer Cell.

More... (http://www.news-medical.net/news/20120612/Normal-p53-gene-makes-breast-cancer-chemotherapy-with-doxorubicin-less-effective.aspx)